Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 28 X 20 mg |
|
13767 | 3909 |
Related information
Dosage
See prescribing information for full details.
Indications
Treatment of states of depression and panic disorder.
Contra-Indications
Known hypersensitivity to citalopram or to any of the components of the preparation. Concomitant administration with 5-HT agonists, e.g. sumatriptan. Concomitant administration with MAO Inhibitors, or within 2 weeks following their cessation. A lapse of 7 days must be allowed following cessation of therapy with citalopram and initiation of therapy with MAO inhibitors.
Special Precautions
Reduced hepatic function: Dosage should be restricted to the lower end of the dose range. Reduced renal function: Dose adjustment is not necessary in cases of mild or moderate renal impairment. No information is available in cases of severe renal impairment.
Contact distributing company for full details.
Side Effects
Contact distributing company for full details.
Drug interactions
5-HT agonists, e.g. sumatriptan, MAOIs.
